Skip to main content
Clinical Trials/NCT02109471
NCT02109471RecruitingNot Applicable

Observational Study of Corneal Opacities in Adults

Oregon Health and Science University1 site in 1 country150 target enrollmentStarted: June 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
150
Locations
1
Primary Endpoint
Identification of suitable subjects

Study Overview

Brief Summary

A prospective observational study on corneal opacities (scar and stromal dystrophy) in adults (n=150) will be conducted at OHSU. The Optovue anterior segment OCT will be used to perform 3-D corneal scans. These scans will be used to assess opacity depth and measure corneal thickness (pachymetry), corneal topography (anterior and posterior), and epithelial thickness maps. The ultrahigh-speed MIT OCT prototypes will also be used when they become available. A comprehensive eye examination, Placido-ring corneal topography, ultrasound pachymetry, and Scheimpflug camera imaging, will be performed for comparison.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult (18 & older) patients presenting in OHSU Casey Eye Clinic with corneal opacities (scar and stromal dystrophy)

Exclusion Criteria

  • Inability to give informed consent.
  • Inability to maintain stable fixation for OCT imaging.
  • Inability to commit to required visits to complete the study.

Outcomes

Primary Outcomes

Identification of suitable subjects

Time Frame: 2 years

The primary goal of this observational study is to identify suitable subjects for the clinical trials of OCT-guided transepithelial PTK.

Secondary Outcomes

  • Validate OCT topography(2 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

David Huang

David Huang, MD, PhD, Professor of Ophthalmology, Oregon Health and Science University

Oregon Health and Science University

Study Sites (1)

Loading locations...

Similar Trials